10X Capital Venture Acquisition III Cl A (VCXB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VCXB | AMGN | VRTX | REGN | GSK |
| Company | 10X Capital Venture Acquisition III Cl A | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 10.96 | 314.41 | 444.72 | 980.42 | 45.06 |
| High | 10.96 | 315.81 | 447.78 | 985.00 | 45.19 |
| Low | 10.96 | 312.92 | 442.99 | 978.21 | 44.95 |
| Last | 10.96 | 313.85 | 447.33 | 984.04 | 45.17 |
| Change | unch | +1.38 | +2.12 | +1.75 | +0.19 |
| % Change | unch | +0.44% | +0.48% | +0.18% | +0.42% |
| Volume | 100 | 545,994 | 262,373 | 114,411 | 704,089 |
| 20-Day Average Volume | 60,565 | 2,828,271 | 1,064,098 | 443,665 | 3,333,677 |
| Previous Close | 10.96 | 312.47 | 445.21 | 982.29 | 44.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.88 | 295.70 | 414.79 | 943.40 | 43.48 |
| 20-Day Raw Stochastic | 81.82% | 85.78% | 99.55% | 94.56% | 85.82% |
| 20-Day Relative Strength | 63.54% | 64.63% | 72.90% | 61.20% | 66.93% |
| Weighted Alpha | +5.50 | +42.38 | +36.75 | +34.62 | +35.42 |
| Today's Opinion | 100% Buy | 72% Buy | 72% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.83% since 04/26/24 | +1.96% since 05/13/24 | +4.05% since 05/13/24 | +0.59% since 05/13/24 | unch since 05/13/24 |
| Low | 10.90 on 05/07/24 | 307.47 on 05/14/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
| High | 10.97 on 05/03/24 | 321.44 on 05/15/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | +0.87% since 04/12/24 | +16.95% since 04/19/24 | +13.45% since 04/19/24 | +9.58% since 04/19/24 | +13.64% since 04/19/24 |
| Low | 10.82 on 04/15/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 39.96 on 04/22/24 |
| High | 11.00 on 04/19/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +2.14% since 02/13/24 | +10.93% since 02/20/24 | +6.35% since 02/20/24 | +3.79% since 02/20/24 | +7.50% since 02/20/24 |
| Low | 10.73 on 02/21/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 11.00 on 04/19/24 | 322.60 on 05/03/24 | 447.58 on 05/20/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +2.72% since 11/09/23 | +18.53% since 11/20/23 | +25.36% since 11/20/23 | +22.59% since 11/20/23 | +28.65% since 11/20/23 |
| Low | 10.68 on 12/08/23 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 35.13 on 11/22/23 |
| High | 11.00 on 04/19/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 166,691 | 167,619,840 | 114,887,776 | 108,234,592 | 93,218,352 |
| Shares Outstanding, K | 15,209 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | 700,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -2,290,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.07 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | N/A | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.89 | 29.26 | 26.08 | 11.11 |